83 related articles for article (PubMed ID: 24413679)
1. Intraoperative CD133+ cell transplantation during coronary artery bypass grafting in ischemic cardiomyopathy.
Klein HM; Assmann A; Lichtenberg A; Heke M
Multimed Man Cardiothorac Surg; 2010 Jan; 2010(809):mmcts.2009.003947. PubMed ID: 24413679
[TBL] [Abstract][Full Text] [Related]
2. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
[TBL] [Abstract][Full Text] [Related]
3. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.
Yoo KJ; Kim HO; Kwak YL; Kang SM; Jang YS; Lim SH; Hwang KC; Cho SW; Yang YS; Li RK; Kim BS
Can J Surg; 2008 Aug; 51(4):269-75. PubMed ID: 18815649
[TBL] [Abstract][Full Text] [Related]
5. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
[TBL] [Abstract][Full Text] [Related]
6. The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133
Noiseux N; Mansour S; Weisel R; Stevens LM; Der Sarkissian S; Tsang K; Crean AM; Larose E; Li SH; Wintersperger B; Vu MQ; Prieto I; Li RK; Roy DC; Yau TM
J Thorac Cardiovasc Surg; 2016 Dec; 152(6):1582-1588.e2. PubMed ID: 27665225
[TBL] [Abstract][Full Text] [Related]
7. Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: initial results from a prospective phase I multicenter trial.
Assmann A; Heke M; Kröpil P; Ptok L; Hafner D; Ohmann C; Martens A; Karluβ A; Emmert MY; Kutschka I; Sievers HH; Klein HM
PLoS One; 2014; 9(7):e101449. PubMed ID: 25000346
[TBL] [Abstract][Full Text] [Related]
8. Functional recovery of patients with ischemic cardiomyopathy treated with coronary artery bypass surgery and concomitant intramyocardial bone marrow mononuclear cell implantation--a long-term follow-up study.
Trifunović Z; Obradović S; Balint B; Ilić R; Vukić Z; Šišić M; Kostić J; Rusović S; Dobrić M; Ostojić G
Vojnosanit Pregl; 2015 Mar; 72(3):225-32. PubMed ID: 25958473
[TBL] [Abstract][Full Text] [Related]
9. The combined use of transmyocardial laser revascularisation and intramyocardial injection of bone-marrow derived stem cells in patients with end-stage coronary artery disease: one year follow-up.
Konstanty-Kalandyk J; Piątek J; Miszalski-Jamka T; Rudziński P; Walter Z; Bartuś K; Urbańczyk-Zawadzka M; Sadowski J
Kardiol Pol; 2013; 71(5):485-92. PubMed ID: 23788089
[TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative isolation and processing of BM-derived stem cells.
Ghodsizad A; Klein HM; Borowski A; Stoldt V; Feifel N; Voelkel T; Piechaczek Ch; Burchardt E; Stockschläder M; Gams E
Cytotherapy; 2004; 6(5):523-6. PubMed ID: 15512919
[TBL] [Abstract][Full Text] [Related]
12. Intramyocardial implantation of autologous bone marrow-derived stem cells combined with coronary artery bypass grafting in patients with ischemic cardiomyopathy: a pilot study.
Antonitsis P; Anastasiadis K; Koliakos G; Vaitsopoulou C; Kouzi-Koliakou K; Doumas A; Argiriadou H; Tossios P
Hippokratia; 2012 Oct; 16(4):366-70. PubMed ID: 23935319
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study.
Patel AN; Geffner L; Vina RF; Saslavsky J; Urschel HC; Kormos R; Benetti F
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1631-8. PubMed ID: 16308009
[TBL] [Abstract][Full Text] [Related]
14. Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial.
Donndorf P; Kaminski A; Tiedemann G; Kundt G; Steinhoff G
Trials; 2012 Jul; 13():99. PubMed ID: 22747980
[TBL] [Abstract][Full Text] [Related]
15. Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: preliminary results in a highly selected small patient cohort.
Babin-Ebell J; Sievers HH; Charitos EI; Klein HM; Jung F; Hellberg AK; Depping R; Sier HA; Marxsen J; Stoelting S; Kraatz EG; Wagner KF
Thorac Cardiovasc Surg; 2010 Feb; 58(1):11-6. PubMed ID: 20072970
[TBL] [Abstract][Full Text] [Related]
16. Intramyocardial Bone Marrow Stem Cells in Patients Undergoing Cardiac Surgical Revascularization.
Chan JL; Miller JG; Zhou Y; Robey PG; Stroncek DF; Arai AE; Sachdev V; Horvath KA
Ann Thorac Surg; 2020 Apr; 109(4):1142-1149. PubMed ID: 31526779
[TBL] [Abstract][Full Text] [Related]
17. Autologous CD133 + Cells and Laser Revascularization in patients with severe Ischemic Cardiomyopathy.
Abdel-Latif A; Ahmed T; Leung SW; Alnabelsi T; Tarhuni W; Sekela ME
Stem Cell Rev Rep; 2023 Apr; 19(3):817-822. PubMed ID: 36376770
[TBL] [Abstract][Full Text] [Related]
18. Effective combined off-pump surgical treatment and autologous bone marrow cell transplantation: a new alternative for patients with end-stage ischemic cardiomyopathy (Prapas' procedure).
Prapas S; Protogeros D; Danou F; Trikka C; Panagiotopoulos I; Chandrinou H
Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():101-7. PubMed ID: 19028642
[TBL] [Abstract][Full Text] [Related]
19. Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction.
Soetisna TW; Sukmawan R; Setianto B; Mansyur M; Murni TW; Listiyaningsih E; Santoso A
J Card Surg; 2020 Apr; 35(4):740-746. PubMed ID: 32048356
[TBL] [Abstract][Full Text] [Related]
20. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.
Dib N; Michler RE; Pagani FD; Wright S; Kereiakes DJ; Lengerich R; Binkley P; Buchele D; Anand I; Swingen C; Di Carli MF; Thomas JD; Jaber WA; Opie SR; Campbell A; McCarthy P; Yeager M; Dilsizian V; Griffith BP; Korn R; Kreuger SK; Ghazoul M; MacLellan WR; Fonarow G; Eisen HJ; Dinsmore J; Diethrich E
Circulation; 2005 Sep; 112(12):1748-55. PubMed ID: 16172284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
